Vertex Pharmaceuticals Inc. stock rises Friday, still underperforms market
This was the stock's third consecutive day of gains.
MIT Technology Review15h
Stem-cell therapies that work: 10 Breakthrough Technologies 2025
After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes.
Levi & Korsinsky Announces an Investigation on Behalf of Vertex Pharmaceuticals Incorporated (VRTX) Shareholders Who May Have Been Affected by Fraud
NEW YORK, NY / ACCESSWIRE / January 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...
Fintel on MSN22h
Raymond James Downgrades Vertex (VERX)
Fintel reports that on January 3, 2025, Raymond James downgraded their outlook for Vertex (NasdaqGM:VERX) from Outperform to ...